While Germany's DAX benchmark .GDAXI fell 0.3%, gains in pharma heavyweight Roche after positive trial news kept the STOXX 600 benchmark flat by 0820 GMT.
After 5 consecutive daily losses on the MSCI index of world stocks .MIWD00000PUS and seven straight falls in Europe, there was a bounce of sorts.
The pan-European STOXX 600 steadied by 0830 GMT, recovering from the previous session's fall.
The pan-European STOXX 600 steadied near two-year highs on Thursday.
ZENSAR TECH Q4
Revenue up 9.5% at Rs 814 Cr vs Rs 743 Cr
EBIT up 79% at Rs 82 Cr vs Rs 45.8 Cr
EBIT margin at 10% vs 6.1%
Net Profit up 6.9x at Rs 74 Cr vs Rs 10.7 Cr
Other Income at Rs 26.7 Cr vs Loss of Rs 22.8 Cr
All figures are consolidated and comparable QoQ
PERSISTENT TECH Q4
Net Sales up 19% at Rs 344 Cr vs Rs 289 Cr
EBITDA up 15.7% at Rs 191 Cr vs Rs 165 Cr
EBTDA Margin at 55.5% vs 57%
Net Profit up 40.5% at Rs 142 Cr vs Rs 101 Cr
All figures are Consolidated & comparable YoY
OBEROI REALTY Q4
Net Sales up 19% at Rs 344 Cr vs Rs 289 Cr
EBITDA up 15.7% at Rs 191 Cr vs Rs 165 Cr
EBTDA Margin at 55.5% vs 57%
Net Profit up 40.5% at Rs 142 Cr vs Rs 101 Cr
All figures are Consolidated & comparable YoY
GIC HSG FINANCE Q4
PAT At Rs 60 Cr vs Rs 46.6 Cr, Up 28.8% YoY
NII at Rs 109 cr vs Rs 100 cr, up 9%
Revenue From Ops At Rs 296 Cr Vs Rs 266 Cr, Up 11.3% YoY
IDFC BANK Q4
PAT Rs 41.9 Cr vs Rs 176 Cr, Down 76% YoY
NII At Rs 453 Cr vs Rs 502 Cr, Down 10% YoY
Gross NPA At 3.31% vs 5.62% QoQ;
Net NPA At 1.69% vs 2.52% QoQ
Provisions At Rs 242 Cr vs Rs 108.6 Cr , up 2.2x QoQ
RAYMOND Q4
Revenue Rs 1,655 Cr vs Rs 1,506 Cr, Up 10% YoY
EBITDA Rs 176 Cr vs Rs 145 Cr, Up 21% YoY
EBITDA Margin 10.6% vs 9.6% YoY
PAT Rs 53 Cr vs Rs 33 Cr, Up 60% YoY
All Figures Are Consolidated
@BTVI